ACADM

Medium-chain specific acyl-CoA dehydrogenase, mitochondrial · P11310 · ACADM on Sugi Atlas →

0 patent compounds predicted against ACADM, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ACADM by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease PHASE3RECRUITING
Acetylcarnitine and Insulin Sensitivity PHASE2COMPLETED
Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects PHASE2COMPLETED
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis PHASE2UNKNOWN
The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC PHASE1/PHASE2UNKNOWN
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease PHASE2COMPLETED
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients PHASE2COMPLETED
Efficacy and Safety of the Treatment of Pyruvate Dehydrogenase Deficiency Patients With Glycerol Phenylbutyrate (RAVICTI) PHASE2RECRUITING
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension PHASE1COMPLETED
Fatty Acid Oxidation Defects and Insulin Sensitivity nanCOMPLETED
Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Healthy Individuals nanRECRUITING
Systemic Biomarkers of Brain Injury From Hyperammonemia nanRECRUITING
Fasting Tolerance in MCADD-infants nanUNKNOWN
A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders nanCOMPLETED
Ketogenic Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease (ADPKD) nanCOMPLETED
Effects of Parenteral L-carnitine Supplementation in Premature Neonates nanCOMPLETED
Study of Protein Translocation in Patients With Beta-Oxidation Disorders nanCOMPLETED
Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism nanNO_LONGER_AVAILABLE
Acute Nutritional Ketosis in VLCAD Deficiency nanCOMPLETED
Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids nanCOMPLETED
Lifestyle Intervention in Preparation for Pregnancy (LIPP) nanCOMPLETED
KD Treatment for Super-refractory Status Epilepticus nanRECRUITING
The Ketogenic Diet in the Treatment of Behavioral Variant Frontotemporal Dementia nanNOT_YET_RECRUITING
Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy nanWITHDRAWN
Re-energize With Nutrition, Exercise and Weight Loss nanCOMPLETED
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
McArdle Disease Treatment by Ketogenic Diet nanCOMPLETED
Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program nanACTIVE_NOT_RECRUITING
KETO-TUMOR: a Study on Brain Tumors and Central Obesity nanRECRUITING
Exercise Intolerance Study in Long Chain Fatty Acid Oxidation Disorders nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a ACADM binder may also engage these)

ProteinNameSimilarity
P08503 1.000 P08503 →
Q8HXY8 1.000 Q8HXY8 →
P45952 1.000 P45952 →
P41367 1.000 P41367 →
Q3SZB4 1.000 Q3SZB4 →
A5A6I0 1.000 A5A6I0 →
Q5EAD4 1.000 Q5EAD4 →
Q5RF40 0.998 Q5RF40 →
Q5RBD5 0.998 Q5RBD5 →
Q9DBL1 0.998 Q9DBL1 →
A8WP91 0.998 A8WP91 →
Q9VSA3 0.997 Q9VSA3 →
Q3SZI8 0.997 Q3SZI8 →
Q9SWG0 0.995 Q9SWG0 →
C3UVB0 0.995 C3UVB0 →
P0A9V0 0.993 P0A9V0 →
Q9FS88 0.992 Q9FS88 →
P26440 0.992 P26440 →
Q54RR5 0.990 Q54RR5 →
P70584 0.990 P70584 →
Q75IM9 0.989 Q75IM9 →
Q2LQP0 0.989 Q2LQP0 →
Q9FS87 0.989 Q9FS87 →
Q22347 0.989 Q22347 →
A8XNF0 0.988 A8XNF0 →
P12007 0.988 P12007 →
P0A9U8 0.988 P0A9U8 →
Q9JHI5 0.987 Q9JHI5 →
P0A9U9 0.986 P0A9U9 →
P45954 0.985 P45954 →